Disintegration of the mesenteric mast cell after the treatments with FOY and aprotinin in guinea pig.
D000818:Animals; D007611:Aprotinin / Q000009:adverse effects*; D016670:Gabexate; D006146:Guanidines / Q000009:adverse effects*; D006168:Guinea Pigs; D008297:Male; D008407:Mast Cells / Q000187:drug effects*; D008643:Mesentery / Q000166:cytology; D011480:Protease Inhibitors / Q000009:adverse effects*
D006146:Guanidines; D011480:Protease Inhibitors; D016670:Gabexate; D007611:Aprotinin